Dr. Yanzhuang Wang is currently a Senior Principal Investigator at Shenzhen Bay Laboratory (SZBL). Before that He was a Professor in the Department of Molecular, Cellular, and Developmental Biology and the Department of Neurology at the University of Michigan. He has successfully mentored numerous junior scientists. He has extensive research experience in cell biology, biochemistry, molecular biology, neurobiology, and endocrinology. His research into Golgi biogenesis, function, and defects has led to breakthroughs with implications for diseases such as cancer, diabetes, SARS-CoV-2 infection, and Alzheimer’s. He is passionate about converging research, disease treatment, and drug development. His overarching goal is to leverage his extensive expertise and leadership in innovative research and therapeutic interventions to make a meaningful impact on human health.
Dr. Wang dedicated to innovative research and made significant contributions to the field. He characterized Golgi stacking proteins GRASP55 and GRASP65, unveiling the mechanism and function of Golgi stack formation. He identified GRASP55 as an energy sensor that controls autophagosome maturation in response to cellular stresses. Additionally, He revealed that p97-mediated post-mitotic Golgi membrane fusion is regulated by monoubiquitination. More recently, He has explored the causes of Golgi defects and their effects on human diseases. He has published over 100 peer-reviewed articles, 9 academic monographs, and edited two books.